drugset / Trial / NCT06580587

A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)

NCT06580587

Phase 1 Completed 13 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The goal of this study is to learn how MK-8527 moves through the healthy person's body over time. Researchers will measure for the amount of MK-8527 in breast milk that the baby will receive at many time points.

Timeline

Start
2025-04-15
Primary completion
2026-03-27
Completion
2026-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-8527 Small molecule Oral

Indications

No indication recorded.